Back to search

Netherlands· NL-fe01dd18a6b7

Pentasa Compact 2 g, granulaat met verlengde afgifte

A mesalazine product containing mesalazine, registered in Netherlands by Euro Registratie Collectief B.V.. The same ATC class is registered in 17 of our 19 countries.

ATC A07EC02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedPentasa Compact 2 g, granulaat met ve…ATCA07EC02REGISTER NO.NL-fe01dd18a6b7PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Mesalazine is registered in 17 of 19 countries.

Countries holding a registration under ATC A07EC02 (mesalazine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose

Mesalazine · ATC A07EC02

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of mesalazine costs, country by country.

Normalised to the WHO defined daily dose (1.5 g), the median price runs from $1.00 in Italy to $2.13 in Switzerland — a ×2.1 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Mesalazine · price per daily dose (1.5 g)

USD · FX 28 Sept 2026

  • CH Switzerland$2.13
  • FR France$1.06
  • IT Italy$1.00
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
MESALAZINE
Manufacturer
Euro Registratie Collectief B.V.
Country
Netherlands (NL)
ATC code
A07EC02
ATC class
Mesalazine
Defined daily dose
1.5 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    120180//31379

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

333 interactions on record for mesalazine.

Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Mesalazine · interactions on record

333 records

  • 15 severe
  • 95 moderate
  • 223 info

Most severe, free to view

  • CidofovirJ05AB12severe
  • Humane Immunglobuline, unspezifisch, extravaskulärJ06BA01severe
  • Humane Immunglobuline, unspezifisch, intravaskulärJ06BA02severe
  • SirolimusL01EG04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Mesalazine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mesalazine products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Azzavix, Claversal
  • Belgium · Asamovon, Claversal
  • Bulgaria · Salofalk – Салофалк, Пентаза
  • Cyprus · Asacol, Mecolzine
  • Czechia · Asacol, Asacol Enema
  • Germany · Asacol, Claversal
  • Denmark · Asacol, Mesalazin Orion
  • Estonia · Asacol, Pentasa
  • Spain · Asacol, Azzavix
  • Finland · Asacol, Asacol 1 G
  • France · Fivasa, Mazalvix
  • United Kingdom (Northern Ireland) · Asacol, Mesalazine
  • Greece · Asacol, Asalazin
  • Croatia · Pentasa, Salofalk
  • Hungary · Pentasa, Salofalk
  • Ireland · Asacolon, Galtasa
  • Iceland · Asacol, Pentasa
  • Italy · Argonal, Asacol
  • Lithuania · Asacol, Pentasa
  • Luxembourg · Claversal, Claversal Foam
  • Latvia · Asacol, Pentasa
  • Malta · Mecolzine, Mezavant Xl
  • Norway · Asacol, Mesalazin Orion
  • Poland · Crohnax, Granmesa
  • Portugal · Asacol, Azzavix
  • Romania · Mesalazina Alfasigma, Pentasa
  • Sweden · Asacol, Mesalazin Orion
  • Slovenia · Asacol, Asacol®
  • Slovakia · Pentasa, Pentasa Sachet

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5cbc08ee-6632-4646-a868-0e1836806aa1
GET /v1/drugs/5cbc08ee-6632-4646-a868-0e1836806aa1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Granulaat met verlengde afgifte",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h31379_smpc.pdf",
  "strength": null,
  "atc_label": "Mesalazine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg120180",
  "excipients": [
    "ETHYLCELLULOSE (E 462)",
    "POVIDON (E 1201)"
  ],
  "substances": [
    "MESALAZINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h120180.pdf",
  "authorised_at": "2017/03/06",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "120180//31379",
  "additional_monitoring": "N"
}

See everything about mesalazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.